Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that HotCars recently ranked Mullen and its EV crossover, the FIVE, No. 2 among the publication’s annual “10 EV Startups to Watch Out For” honorees for 2022. “I am delighted that the world is starting to take notice of the Mullen FIVE and…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system (“CNS”), has entered into securities purchase agreements with several institutional and accredited investors. The agreements outline the issue of more than 12 million shares of common stock, prefunded warrants…
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the appointment of accomplished business leader and cannabis industry expert Tim Leslie as the chairman of its newly formed advisory board. Establishment of the advisory board comes as Flora continues to develop its corporate structure to include a…
Excellon Resources (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) has shared an overview of its operations. The update includes information regarding EXN’s Platosa project as well as other upcoming exploration plans; the company stated that additional updates would be forthcoming. The company noted that last year the Platosa mine and the Miguel Auza mill produced four quarters of…
PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) recently announced the expansion of its e-commerce platform to the United Kingdom. The new platform, www.PlantX.uk, will offer customers a similar experience as PlantX’s customers in Canada and the United States, introducing a wide selection of novel brands and products for the growing plant-based community in…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has scheduled several industry-specific events for 2022. The company has announced its initial schedule for 2022 conferences. The company will hold its first event — the Sequire Metals & Mining Conference — on…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, has released a shareholder letter. The letter, from president and CEO Eric A. Adams, provided INM shareholders with a company update, including a look at key milestones the company had reached, including the acquisition of BayMedica, which Adams said positioned…
As a significant number of drugs fail to reach the market owing to poor bioavailability, Lexaria Bioscience Corp. (NASDAQ: LEXX) is among those companies exploring different tools and methods to try to solve the problem. Lexaria is currently leading the industry in terms of innovation in drug delivery platforms. “Its patented DehydraTECH(TM) technology is specifically…
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is marking key milestones to revolutionize mental health care. Among these, the company recently secured a grant for the first-ever psychedelic treatment clinic at Lenox Hill Hospital. The hospital is part of Northwell Health, the largest health care system in…
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, recently completed the initial shipment of its sugarBEAT(R) continuous glucose monitor (“CGM”) devices to its U.K. licensee, MySugarWatch Limited. “MySugarWatch will market the sugarBEAT product under the MySugarWatch(R) brand and has developed…
FingerMotion (NASDAQ: FNGR), a mobile data and services company with evolving technology and a core competency in mobile payment and recharge platform solutions in China, today announced that it has recently retained the services of Skyline Corporate Communications Group LLC. Under the collaboration, Skyline will manage FingerMotion’s investor relations and corporate communications activities within the…
AnPac Bio-Medical Science (NASDAQ: ANPC), a U.S.- and China-based biotechnology company focused on early cancer screening and detection, announced that its Class III medical device for lung cancer auxiliary diagnosis has passed stringent and rigorous registration tests; the tests were conducted at a testing laboratory selected by China’s regulatory agent for medical products, the National…
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products, today announced that its Mind Naturals skincare brand has launched sales through Walmart.com and Coppel, a nationwide department store in Mexico. According to the update, the launch includes 12 products from the Mind Naturals portfolio, initially via e-commerce with subsequent plans to…
Growth Capital (NASDAQ: GCAC), a publicly traded special purpose acquisition company listed on Feb. 2, 2021, recently announced its entry into a definitive business combination agreement with Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance Micro Motion Technology (“MMT”(R)) lidar solutions. “Upon closing of the transaction, the combined company will be…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced that its CEO Eric A. Adams, SVP and General Manager of BayMedica, Shane Johnson, and VP of Commercial Operations Chris Meiering will present at Tribe Public’s upcoming webinar presentation and Q&A event. The event, titled “Addressing the Increasing…
Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has issued 6,784,812 shares to settle a CAD$5.1 million (US$4.0 million) debt. By settling the debt at a favorable conversion price (approximately CAD$0.75 or US $0.56 per share), RWB will realize an accounting gain of approximately CAD$2.3…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has received Independent Review Board (“IRB”) approval for its planned DehydraTECH-CBD human hypertension study HYPER-H21-4; the approval was received earlier than anticipated. The study is designed to “de-risk” outcomes prior to the company’s planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat…
Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. Since its founding in 2011, Nemaura set out to develop a single platform technology to measure blood markers at the surface of the skin. Since then, the company has evolved to…
Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently released its financial and operating report for Q2 2021, with notable company milestones and achievements highlighted. The company plans to move through the ongoing remaining preclinical studies for its CYB003 novel deuterated psilocybin analog and…
Tingo (OTCQB: IWBB) appears committed to tackling some of the biggest social and economic challenges Africa faces today through its innovative technology that can uplift rural communities and open international opportunities. Challenges faced by African agriculture are considerable, from food waste and substantial inefficiencies to being considerably underfunded. However, technology can help. “According to the…